Skip to main content
SpringerLink
Log in

Therapeutic plasma exchange in hyperthyroidism prior to surgery

  • Original Article
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Purpose

Therapeutic plasma exchange (TPE) is a treatment option to reduce thyroid hormones in the event of contraindication or unresponsiveness to antithyroid drugs (ATDs).

Methods

We analyzed 11 patients with hyperthyroidism who received TPE prior to surgery between January 2008 and December 2016 at our center.

Results

In total, 41 processes were applied to 11 patients with hyperthyroidism. The median age was 40 years, and 90.9% of the patients were female. Seven patients had Graves’ disease, while four had a toxic multinodular goiter. The distribution of TPE indications comprised contraindication to ATDs (64%) and insufficient response to ATDs (36%). An adequate response was not obtained with TPE in two patients, and cholestyramine plus methimazole and Lugol solution were applied. The median number of TPE sessions was 3. During the TPE period, a β-blocker was applied concurrently except in one patient who was contraindicated for the drug. The reduction in FT3 and FT4 hormones and the increase in TSH levels were statistically significant after TPE application (p values of 0.003, 0.033 and 0.008, respectively). Regarding adverse events of TPE application, an allergic reaction was seen in one patient, while prolongation of prothrombin time without any clinical findings was seen in another patient. Ten patients underwent total thyroidectomy, and one patient underwent a gynecological surgery procedure without any major complications.

Conclusion

The American Society for Apheresis guideline, which is the most referenced guideline, mentions the utilization of TPE before thyroid surgery, only in patients with thyrotoxicosis despite the wider necessity of this treatment choice under the condition of uncontrolled hyperthyroidism prior to any kind of surgery. We concluded that TPE is a reliable and effective application in patients with hyperthyroidism before any surgical procedure, according to our study results.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Padmanabhan A, Smith LC, Aqui N, Balogun RA, Klingel R, Meyer E, Pham HP, Schneiderman J, Witt V, Wu Y, Zantek ND, Dunbar NM (2019) Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the writing committee of the American Society for apheresis: the eighth special issue. J Clin Apher 34(3):171–354. https://doi.org/10.1002/jca.21705

    Article  Google Scholar 

  2. Ross DS, Burch HB, Cooper DS, Greenlee MC, Laurberg P, Maia AL, Rivkees SA, Samuels M, Sosa JA, Stan MN, Walter MA (2016) 2016 American thyroid association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid 26(10):1343–1421. https://doi.org/10.1089/thy.2016.0229

    Article  Google Scholar 

  3. Simsir IY, Ozdemir M, Duman S, Erdogan M, Donmez A, Ozgen AG (2018) Therapeutic plasmapheresis in thyrotoxic patients. Endocrine 62(1):144–148. https://doi.org/10.1007/s12020-018-1661-x

    Article  CAS  Google Scholar 

  4. Keklik M, Kaynar L, Yilmaz M, Sivgin S, Solmaz M, Pala C, Aribas S, Akyol G, Unluhizarci K, Cetin M, Eser B, Unal A (2013) The results of therapeutic plasma exchange in patients with severe hyperthyroidism: a retrospective multicenter study. Transfus Apheresis Sci 48(3):327–330. https://doi.org/10.1016/j.transci.2013.04.010

    Article  Google Scholar 

  5. Saie C, Ghander C, Saheb S, Jublanc C, Lemesle D, Lepoutre CL, Leenhardt L, Menegaux F, Tresallet C, Buffet C (2021) Therapeutic plasma exchange in refractory hyperthyroidism. Eur Thyroid J 10(1):86–92. https://doi.org/10.1159/000507019

    Article  CAS  Google Scholar 

  6. Baser OO, Cetin Z, Catak M, Koseoglu D, Berker D (2020) The role of therapeutic plasmapheresis in patients with hyperthyroidism. Transfus Apher Sci 59(4):102744. https://doi.org/10.1016/j.transci.2020.102744

    Article  Google Scholar 

  7. Durmus ET, Atmaca A, Ozatlı D, Colak R, Durmus B (2022) Efficacy of preoperative therapeutic plasma exchange in patients with hyperthyroidism and factors affecting the number of sessions. Endocrine 76(1):101–108. https://doi.org/10.1007/s12020-021-02975-9

    Article  CAS  Google Scholar 

  8. Burch HB, Wartofsky L (1993) Life-threatening thyrotoxicosis: thyroid storm. Endocrinol Metab Clinics North Am 22(2):263–277

    Article  CAS  Google Scholar 

  9. Bilir BE, Atile NS, Kirkizlar O, Kömürcü Y, Akpinar S, Sezer A, Demir M, Hekimoğlu S (2013) Effectiveness of preoperative plasmapheresis in a pregnancy complicated by hyperthyroidism and anti-thyroid drug-associated angioedema. Gynecol Endocrinol 29(5):508–510. https://doi.org/10.3109/09513590.2012.754871

    Article  Google Scholar 

  10. Kahaly GJ, Bartalena L, Hegedüs L, Leenhardt L, Poppe K, Pearce SH (2018) 2018 European thyroid association guideline for the management of Graves’ hyperthyroidism. Eur Thyroid J 7(4):167–186. https://doi.org/10.1159/000490384

    Article  CAS  Google Scholar 

  11. Azizi F, Malboosbaf R (2019) Safety of long-term antithyroid drug treatment? A systematic review J Endocrinol Invest 42(11):1273–1283. https://doi.org/10.1007/s40618-019-01054-1

    Article  CAS  Google Scholar 

  12. Suzuki N, Noh JY, Hiruma M, Kawaguchi A, Morisaki M, Ohye H et al (2019) Analysis of antithyroid drug-induced severe liver injury in 18,558 newly diagnosed patients with Graves’ disease in Japan. Thyroid 29(10):1390–1398. https://doi.org/10.1089/thy.2019.0045

    Article  CAS  Google Scholar 

  13. Cooper DS (2005) Antithyroid drugs. N Engl J Med 352(9):905–917. https://doi.org/10.1056/NEJMra042972

    Article  CAS  Google Scholar 

  14. Rojo Alvaro J, Conchillo Fernandez C, Agea Díaz L, Bilboa Garay I, Garcia Delgado C, Molina Del Rio J, Iglesias MMG (2020) Thyroid plasmapheresis. Nefrologia 40(5):566–568. https://doi.org/10.1016/j.nefro.2019.07.004

    Article  Google Scholar 

  15. Guvenc B, Unsal C, Gurkan E, Dincer S (2004) Plasmapheresis in the treatment of hyperthyroidism associated with agranulocytosis: a case report. J Clin Apher 19(3):148–150. https://doi.org/10.1002/jca.20014

    Article  Google Scholar 

  16. Apaydın T, Elbasan O, Yavuz DG (2020) Preoperative plasmapheresis experience in Graves’ disease patients with anti-thyroid drug-induced hepatotoxicity. Transfus Apher Sci 59(5):102826. https://doi.org/10.1016/j.transci.2020.102826

    Article  Google Scholar 

  17. Garla V, Kovvuru K, Ahuja S, Palabindala V, Malhotra B, Abdul SS (2018) Severe hyperthyroidism complicated by agranulocytosis treated with therapeutic plasma exchange: case report and review of the literature. Case Rep Endocrinol 2018:4135940. https://doi.org/10.1155/2018/4135940

    Article  Google Scholar 

  18. Tieken K, Paramasivan AM, Goldner W, Yuil-Valdes A, Fingeret AL (2020) Therapeutic plasma exchange as a bridge to total thyroidectomy in patients with severe thyrotoxicosis. AACE Clin Case Rep 6(1):e14–e18. https://doi.org/10.4158/ACCR-2019-0132

    Article  Google Scholar 

  19. Ezer A, Caliskan K, Parlakgumus A, Belli S, Kozanoglu I, Yildirim S (2009) Preoperative therapeutic plasma exchange in patients with thyrotoxicosis. J Clin Apher 24(3):111–114. https://doi.org/10.1002/jca.20200

    Article  Google Scholar 

  20. Schwartz J, Padmanabhan A, Aqui N, Balogun RA, Connelly- Smith L, Delaney M, Dunbar NM, Witt V, Wu Y, Shaz BH (2016) Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the writing Committee of the American Society for apheresis: the seventh special issue. J Clin Apher 31(3):149–162. https://doi.org/10.1002/jca.21470

    Article  Google Scholar 

  21. Builes-Montano CE, Rodriguez-Arrieta LA, Roman-Gonzalez A, Prieto-Saldarriaga C, Alvarez-Payares JC, Builes-Barrera CA, Arango-Toro CM (2021) Therapeutic plasmapheresis for the treatment of thyrotoxicosis: A retrospective multi-center study. J Clin Apher 36(5):759–765. https://doi.org/10.1002/jca.21927

    Article  Google Scholar 

  22. Shemin D, Briggs D, Greenan M (2007) Complications of therapeutic plasma exchange: a prospective study of 1,727 procedures. J Clin Apher 22(5):270–276. https://doi.org/10.1002/jca.20143

    Article  Google Scholar 

  23. Orlin JB, Berkman EM (1980) Partial plasma exchange using albumin replacement: removal and recovery of normal plasma constituents. Blood 56(6):1055–1059

    Article  CAS  Google Scholar 

  24. Wood L, Jacobs P (1986) The effect of serial therapeutic plasmapheresis on platelet count, coagulation factors, plasma immunoglobulin, and complement levels. J Clin Apher 3(2):124–128

    Article  CAS  Google Scholar 

  25. Zantek ND, Boral LI, Li Y, Yamada C, Svensson AM, Crane JE et al (2018) Hemostasis management and therapeutic plasma exchange: results of a practice survey. J Clin Apher 33(5):604–610. https://doi.org/10.1002/jca.21653

    Article  Google Scholar 

  26. Tanska K, Leszczynska D, Glinicki P, Kapuscinska R, Szczepkowski M, Dedecjus M, Stachlewska-Nasfeter E, Brym I, Zelek T, Daniewska D, Gietka-Czernel M (2021) Therapeutic plasma exchange with albumin as a valuable method of preparing thyrotoxic patients for a life-saving thyroidectomy. J Clin Apher 36(3):496–498. https://doi.org/10.1002/jca.21866

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hematology, Trakya University Medical Faculty, Edirne, Turkey

    H. O. Kirkizlar

  2. Department of Endocrinology, Trakya University Medical Faculty, Edirne, Turkey

    M. Celik

Authors
  1. H. O. Kirkizlar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Celik
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to H. O. Kirkizlar.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kirkizlar, H.O., Celik, M. Therapeutic plasma exchange in hyperthyroidism prior to surgery. J Endocrinol Invest 46, 173–179 (2023). https://doi.org/10.1007/s40618-022-01897-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40618-022-01897-1

Keywords

Search

Navigation